Literature DB >> 11800271

N-glycosylation of yeast, with emphasis on Candida albicans.

J E Cutler1.   

Abstract

Fungal cell wall N-linked glycans have been studied most extensively in Saccharomyces cerevisiae and in Candida albicans. The glycans are located on the fungal cell surface in the form of phosphomannoprotein complexes and the amount of glycosylation is influenced both by genetics and environmental factors. The glycans, which are comprised mostly of mannan, are important in fungal-host interactions, as they make first contact with the immune system. Initial N-linked glycosylation events take place in the endoplasmic reticulum and are conserved throughout all eukaryotes, but yeasts are capable of additional glycosylation that may result in a glycan comprised of more than 200 mannose units. In C. albicans, the glycan can be delineated into an inner mannan core, which is similar to mammalian glycoproteins, an alpha-linked mannan backbone with alpha-oligomannosyl side chains, and beta(1,2)-oligomannosides which are phosphodiester linked to the alpha-mannan. Both the beta-oligomannosides, which make up the acid-labile part of the phosphomannan complex, and alpha-oligomannosides, which make up the acid-stable part of the complex, serve as adhesins in the attachment of C. albicans yeast cells to host splenic and lymph node macrophages. The beta-oligomannosides can induce release of tumour necrosis factor (TNF)-alpha, and antibodies specific to certain beta-oligomannosides enhance host resistance to various forms of candidiasis. The importance of the N-linked glycans in fungal-host interactions provides rationale for further studies, which may well lead to effective immunotherapeutic strategies for prevention and, possibly, treatment of disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11800271

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  29 in total

1.  Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccines.

Authors:  Michael Luong; Jennifer S Lam; Jianmin Chen; Stuart M Levitz
Journal:  Vaccine       Date:  2007-03-30       Impact factor: 3.641

Review 2.  Candida albicans-endothelial cell interactions: a key step in the pathogenesis of systemic candidiasis.

Authors:  Sarah E W Grubb; Craig Murdoch; Peter E Sudbery; Stephen P Saville; Jose L Lopez-Ribot; Martin H Thornhill
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

3.  Antifungal Properties of Cationic Phenylene Ethynylenes and Their Impact on β-Glucan Exposure.

Authors:  Harry C Pappas; Rina Sylejmani; Matthew S Graus; Patrick L Donabedian; David G Whitten; Aaron K Neumann
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

4.  Structure-activity relationship study of the plant-derived decapeptide OSIP108 inhibiting Candida albicans biofilm formation.

Authors:  Nicolas Delattin; Katrijn De Brucker; David J Craik; Olivier Cheneval; Barbara De Coninck; Bruno P A Cammue; Karin Thevissen
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

Review 5.  Exploiting fungal cell wall components in vaccines.

Authors:  Stuart M Levitz; Haibin Huang; Gary R Ostroff; Charles A Specht
Journal:  Semin Immunopathol       Date:  2014-11-18       Impact factor: 9.623

6.  Murine model of dextran sulfate sodium-induced colitis reveals Candida glabrata virulence and contribution of β-mannosyltransferases.

Authors:  Samir Jawhara; Estelle Mogensen; François Maggiotto; Chantal Fradin; Aurore Sarazin; Laurent Dubuquoy; Emmanuel Maes; Yann Guérardel; Guilhem Janbon; Daniel Poulain
Journal:  J Biol Chem       Date:  2012-01-30       Impact factor: 5.157

7.  Evaluation of immunostimulatory activities of synthetic mannose-containing structures mimicking the β-(1->2)-linked cell wall mannans of Candida albicans.

Authors:  Kaarina Ranta; Kaisa Nieminen; Filip S Ekholm; Moniká Poláková; Mattias U Roslund; Tiina Saloranta; Reko Leino; Johannes Savolainen
Journal:  Clin Vaccine Immunol       Date:  2012-09-19

Review 8.  Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.

Authors:  James Masuoka
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

9.  Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.

Authors:  Carla Bromuro; Antonella Torosantucci; Paola Chiani; Stefania Conti; Luciano Polonelli; Antonio Cassone
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  Role of Candida albicans secreted aspartyl protease Sap9 in interkingdom biofilm formation.

Authors:  Lindsay C Dutton; Howard F Jenkinson; Richard J Lamont; Angela H Nobbs
Journal:  Pathog Dis       Date:  2016-01-14       Impact factor: 3.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.